Trial of Nivolumab With Chemotherapy as Neoadjuvant Treatment in Inflammatory Breast Cancer (IBC)
Completed · Phase 2
Conditions studied: Breast Cancer
In brief
Study of efficacy of nivolumab with neoadjuvant chemotherapy in patients with IBC
Key facts
- Study ID
- NCT03742986
- Run by
- NYU Langone Health
- People needed
- 8
- Starts
- 2019-05-02
- Expected to finish
- 2023-06-12
- Last updated by the study team
- 2023-12-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Newly diagnosed inflammatory breast cancer without distant metastases and have not received prior chemotherapy or immunotherapy. All breast cancer subtypes are allowed: Triple negative breast cancer (TNBC); Hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative; HR-positive or HR-negative and HER2-positive
You may not qualify if…
- Clinical or radiologic evidence of distant metastases
- Malignancy that progressed within the last five years.
- Cardiac disease (history of and/or active disease)
- HIV positive
- Neuropathy ≥ Grade 2, per the NCI CTCAE v5.0
- Allogeneic stem cell or solid organ transplantation
- Autoimmune disease where in the opinion of the Investigator would preclude the use of immunotherapy
- Idiopathic pulmonary fibrosis, organizing pneumonia (e.g., bronchiolitis obliterans), or evidence of active pneumonitis
- Tuberculosis
- Pregnancy or lactation
- Treatment with CD137 agonists or immune checkpoint-blockade therapies, including anti-CD40, anti-CTLA-4, anti-PD-1, and anti-PD-L1 therapeutic antibodies
- Treatment with systemic immunosuppressive medications
- Cardiopulmonary dysfunction
- Clinically significant history of liver disease, including cirrhosis, autoimmune hepatic disorders, HIV infection, or active Hepatitis B or Hepatitis C
- Subject is pregnant or nursing
- Known hypersensitivity to the components of the study drugs(s)
Where it is running
- Indiana University — Bloomington, Indiana, United States
- NYU Langone Health — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.